Galmed Pharmaceuticals Company Profile (NASDAQ:GLMD)

About Galmed Pharmaceuticals

Galmed Pharmaceuticals logoGalmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product candidate, aramchol, is a disease modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis (NASH). The Company's Aramchol is a conjugate of cholic acid and arachidic acid, which is a member of synthetic Fatty-Acid/Bile-Acid Conjugates (FABACs). FABACs are composed of endogenic compounds. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis (NASH). Aramchol is in Phase IIb clinical trials.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: GLMD
  • CUSIP:
Key Metrics:
  • Previous Close: $4.19
  • 50 Day Moving Average: $4.14
  • 200 Day Moving Average: $3.93
  • 52-Week Range: $2.78 - $7.72
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.63
  • P/E Growth: 0.00
  • Market Cap: $50.90M
  • Outstanding Shares: 12,149,000
  • Beta: 2.35
Profitability:
  • Return on Equity: -88.41%
  • Return on Assets: -74.07%
Debt:
  • Current Ratio: 6.53%
  • Quick Ratio: 6.53%
Additional Links:
Companies Related to Galmed Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Galmed Pharmaceuticals (NASDAQ:GLMD) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $14.25 (235.29% upside)

Analysts' Ratings History for Galmed Pharmaceuticals (NASDAQ:GLMD)
Show:
DateFirmActionRatingPrice TargetDetails
11/7/2016HC WainwrightReiterated RatingBuyView Rating Details
8/5/2016FBR & CoSet Price TargetBuy$20.00View Rating Details
8/1/2016Maxim GroupReiterated RatingBuy$24.00 -> $9.00View Rating Details
7/6/2016Roth CapitalReiterated RatingBuy$6.00View Rating Details
8/19/2015MLV & Co.Reiterated RatingBuy$24.00View Rating Details
8/14/2015SunTrust Banks, Inc.Lower Price TargetBuy$20.00 -> $19.00View Rating Details
(Data available from 2/22/2015 forward)

Earnings

Earnings History for Galmed Pharmaceuticals (NASDAQ:GLMD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/20/2017        
11/7/2016Q3($0.39)($0.34)ViewListenView Earnings Details
8/3/2016Q216($0.35)($0.39)ViewN/AView Earnings Details
5/16/2016Q116($0.33)($0.36)ViewListenView Earnings Details
3/22/2016Q415($0.28)($0.29)ViewListenView Earnings Details
11/9/2015Q315($0.29)($0.23)ViewN/AView Earnings Details
8/13/2015Q215($0.28)($0.21)ViewListenView Earnings Details
5/13/2015Q1($0.26)($0.22)ViewListenView Earnings Details
3/31/2015($0.36)($0.15)ViewN/AView Earnings Details
11/12/2014Q314($0.37)($0.62)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Galmed Pharmaceuticals (NASDAQ:GLMD)
Current Year EPS Consensus Estimate: $-1.39 EPS
Next Year EPS Consensus Estimate: $-1.17 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.32)($0.32)($0.32)
Q2 20163($0.41)($0.26)($0.35)
Q3 20163($0.44)($0.28)($0.37)
Q4 20163($0.34)($0.32)($0.33)
Q1 20171($0.25)($0.25)($0.25)
Q2 20171($0.24)($0.24)($0.24)
Q3 20171($0.23)($0.23)($0.23)
Q4 20171($0.22)($0.22)($0.22)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Galmed Pharmaceuticals (NASDAQ:GLMD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Galmed Pharmaceuticals (NASDAQ:GLMD)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Galmed Pharmaceuticals (NASDAQ:GLMD)
DateHeadline
News IconEarnings Reaction History: Galmed Pharmaceuticals Ltd. (GLMD) Post Earnings Price Moves - Post Analyst (NASDAQ:GLMD)
postanalyst.com - February 13 at 11:20 PM
News IconTicker Watch: Technical Views on Shares of Galmed Pharmaceuticals Ltd. (GLMD) - Sherwood Daily (NASDAQ:GLMD)
sherwooddaily.com - February 4 at 5:31 PM
News IconInvestor Guide: Check on Technical Levels for Galmed Pharmaceuticals Ltd. (GLMD) - Sherwood Daily (NASDAQ:GLMD)
sherwooddaily.com - February 2 at 6:04 PM
News IconTechnical Trading: Focus on Shares of Galmed Pharmaceuticals Ltd. (GLMD) - Sherwood Daily (NASDAQ:GLMD)
sherwooddaily.com - February 2 at 6:04 PM
News IconGrowth Story Unfolding for Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) - Prospect Journal (NASDAQ:GLMD)
prospectjournal.com - January 30 at 11:10 PM
News IconInvestor Focus on Technical Levels for Galmed Pharmaceuticals Ltd. (GLMD) - Sherwood Daily (NASDAQ:GLMD)
sherwooddaily.com - January 30 at 11:10 PM
News IconEarnings Analysis & Update for Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD)? - Aiken Advocate (NASDAQ:GLMD)
aikenadvocate.com - January 29 at 5:28 PM
News IconAverage Directional Index Review for Galmed Pharmaceuticals Ltd. (GLMD) - Sherwood Daily (NASDAQ:GLMD)
sherwooddaily.com - January 27 at 7:20 PM
News IconSell-side is Weighing in on Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Earnings & Targets - Aiken Advocate (NASDAQ:GLMD)
aikenadvocate.com - January 26 at 11:53 PM
News IconInvestors are Looking at Levels for Galmed Pharmaceuticals Ltd. (GLMD) - Sherwood Daily (NASDAQ:GLMD)
sherwooddaily.com - January 26 at 2:48 AM
News IconBrokers Release Average Price Target Of 16.00 On Galmed Pharmaceuticals Ltd. (GLMD) - UK Market News (NASDAQ:GLMD)
www.ukmarketnews.co.uk - January 26 at 2:48 AM
News IconEarnings in Full Force, Analysts Take Aim at Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) - Wall Street Beacon (NASDAQ:GLMD)
wsbeacon.com - January 25 at 4:11 AM
News IconInvestor Sphere: Keeping an Eye on Levels for Galmed Pharmaceuticals Ltd. (GLMD) - Sherwood Daily (NASDAQ:GLMD)
sherwooddaily.com - January 24 at 3:50 AM
News IconTrump Sworn In as S&P Declined, How Did this Stock Perform This Week: Galmed Pharmaceuticals Ltd. (NASDAQ ... - Aiken Advocate (NASDAQ:GLMD)
aikenadvocate.com - January 22 at 2:03 AM
News IconSteering Attention Towards Earnings; Analysts Weigh in on Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Stock - Aiken Advocate (NASDAQ:GLMD)
aikenadvocate.com - January 21 at 4:47 AM
News IconGalmed Pharmaceuticals Ltd. (GLMD) Under Analyst Spotlight - UK Market News (NASDAQ:GLMD)
www.ukmarketnews.co.uk - January 19 at 7:11 PM
News IconCCI, MA, and RSI in Focus for Galmed Pharmaceuticals Ltd. (GLMD) - Sherwood Daily (NASDAQ:GLMD)
sherwooddaily.com - January 17 at 3:24 PM
News IconWill The Needle Move For Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:GLMD)
wsbeacon.com - January 17 at 3:24 PM
nasdaq.com logoEGLT Gets Long Awaited FDA Approval, PTCT Breathes Easy, GLMD On Track - Nasdaq (NASDAQ:GLMD)
www.nasdaq.com - January 11 at 11:03 PM
finance.yahoo.com logoGalmed Pharmaceuticals Completes Patient Recruitment for ARREST Phase IIb NASH study (NASDAQ:GLMD)
finance.yahoo.com - January 9 at 4:14 PM
News IconGalmed Pharmaceuticals Ltd. (GLMD) – Latest Broker Consensus - NewsDen (NASDAQ:GLMD)
newsden.net - January 6 at 6:02 PM
News IconReviewing Indicator Levels for Galmed Pharmaceuticals Ltd. (GLMD) - Yankee Analysts (NASDAQ:GLMD)
yankeeanalysts.com - December 21 at 11:21 PM
News IconInvestor Technical Review for Galmed Pharmaceuticals Ltd. (GLMD) - Yankee Analysts (NASDAQ:GLMD)
yankeeanalysts.com - December 18 at 3:45 AM
News IconLooking at the Technicals for Galmed Pharmaceuticals Ltd. (GLMD) - StockTalk Daily (NASDAQ:GLMD)
stocktalkdaily.com - December 4 at 10:41 AM
News IconGalmed Pharmaceuticals Ltd. (GLMD) Valuation According To Analysts - UK Market News (NASDAQ:GLMD)
www.ukmarketnews.co.uk - November 30 at 10:34 PM
News IconIndicator Level Summary for Galmed Pharmaceuticals Ltd. (GLMD) - Yankee Analysts (NASDAQ:GLMD)
yankeeanalysts.com - November 24 at 8:12 AM
News IconMA in Focus for Galmed Pharmaceuticals Ltd. (GLMD) - MicroCap Wired (NASDAQ:GLMD)
www.microcapwired.com - November 22 at 5:05 PM
News IconMA in Focus for Galmed Pharmaceuticals Ltd. (GLMD) - MicroCap Wired (NASDAQ:GLMD)
www.microcapwired.com - November 22 at 5:05 PM
News IconLooking at the Technicals for Galmed Pharmaceuticals Ltd. (GLMD) - MicroCap Wired (NASDAQ:GLMD)
www.microcapwired.com - November 22 at 8:43 AM
News IconTrading Watch: ADX and CCI Review for Galmed Pharmaceuticals Ltd. (GLMD) - MicroCap Wired (NASDAQ:GLMD)
www.microcapwired.com - November 21 at 10:21 AM
News IconTracking Technical Levels on Shares of Galmed Pharmaceuticals Ltd. (GLMD) - MicroCap Wired (NASDAQ:GLMD)
www.microcapwired.com - November 18 at 7:34 AM
News IconGalmed Pharmaceuticals Ltd. (GLMD) Shares Slip, Investors ... - The Ledger Gazette (NASDAQ:GLMD)
ledgergazette.com - November 18 at 7:34 AM
fxpips.com logoCompany Stocks Having Gaps Down – ULH, ENZY, KNSL, INSG, ELGX, LNTH, FLXN (NASDAQ:GLMD)
www.fxpips.com - November 17 at 8:21 AM
News IconChecking Moving Average and RSI Levels on Galmed Pharmaceuticals Ltd. (GLMD) - MicroCap Wired (NASDAQ:GLMD)
www.microcapwired.com - November 16 at 8:37 AM
News IconLatest Analyst Consensus For Galmed Pharmaceuticals Ltd. (GLMD) - UK Market News (NASDAQ:GLMD)
www.ukmarketnews.co.uk - November 15 at 8:35 AM
News IconActive Trading Watch on Shares of Galmed Pharmaceuticals Ltd. (GLMD) - Yankee Analysts (NASDAQ:GLMD)
yankeeanalysts.com - November 14 at 5:29 PM
News IconAnalysts Take: Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Projected Earnings & Price Targets - CSZ News (NASDAQ:GLMD)
cincysportszone.com - November 14 at 9:18 AM
News IconChart Indicator Check on Shares of Galmed Pharmaceuticals Ltd. (GLMD) - Yankee Analysts (NASDAQ:GLMD)
yankeeanalysts.com - November 12 at 7:43 AM
News IconRecently Changed Price Targets On Galmed Pharmaceuticals Ltd. (GLMD) - NewsDen (NASDAQ:GLMD)
newsden.net - November 12 at 7:43 AM
News IconMA Levels in Review for Galmed Pharmaceuticals Ltd. (GLMD) - MicroCap Wired (NASDAQ:GLMD)
www.microcapwired.com - November 10 at 10:57 PM
News IconWilliams %R Check on Shares of Galmed Pharmaceuticals Ltd. (GLMD) - MicroCap Wired (NASDAQ:GLMD)
www.microcapwired.com - November 10 at 8:03 AM
News IconMarket Review: Indicator Watch for Galmed Pharmaceuticals Ltd. (GLMD) - Yankee Analysts (NASDAQ:GLMD)
yankeeanalysts.com - November 8 at 10:46 PM
News IconGalmed Pharmaceuticals Reports Third Quarter 2016 Financial Results And Provides Business Update (NASDAQ:GLMD)
www.biospace.com - November 8 at 4:36 PM
News IconTrading Spotlight: Zooming in on Shares of Galmed Pharmaceuticals Ltd. (GLMD) - Yankee Analysts (NASDAQ:GLMD)
yankeeanalysts.com - November 7 at 5:27 PM
finance.yahoo.com logo8:13 am Galmed Pharma reports Q3 result; beats by $0.05; CFO Josh Blacher to leave the co to pursue other opportunities effective Jan 31, 2017 (NASDAQ:GLMD)
finance.yahoo.com - November 7 at 5:27 PM
sg.finance.yahoo.com logoGalmed Pharmaceuticals reports 3Q loss (NASDAQ:GLMD)
sg.finance.yahoo.com - November 7 at 8:39 AM
News IconPenny Stock Update: Looking At Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) - Duncan Research (NASDAQ:GLMD)
www.duncanindependent.com - November 5 at 9:58 AM
News IconIs Trouble Ahead? Stock Looks to Reverse Course in Session: Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) - CSZ News (NASDAQ:GLMD)
cincysportszone.com - October 31 at 11:48 AM
publicnow.com logoGalmed Pharmaceuticals Third Quarter 2016 Conference Call and Webcast Scheduled for Monday, November 7th, 2016 (NASDAQ:GLMD)
www.publicnow.com - October 31 at 11:48 AM
News IconStock Clipped Lower in Past Week: Galmed Pharmaceuticals Ltd ... - CSZ News (NASDAQ:GLMD)
cincysportszone.com - October 30 at 9:52 AM

Social

What is Galmed Pharmaceuticals' stock symbol?

Galmed Pharmaceuticals trades on the NASDAQ under the ticker symbol "GLMD."

Where is Galmed Pharmaceuticals' stock going? Where will Galmed Pharmaceuticals' stock price be in 2017?

4 brokerages have issued 12 month price objectives for Galmed Pharmaceuticals' stock. Their predictions range from $6.00 to $22.00. On average, they anticipate Galmed Pharmaceuticals' share price to reach $14.25 in the next twelve months.

When will Galmed Pharmaceuticals announce their earnings?

Galmed Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Monday, March, 20th 2017.

Who owns Galmed Pharmaceuticals stock?

Galmed Pharmaceuticals' stock is owned by many different of institutional and retail investors. Top institutional investors include GRT Capital Partners L.L.C. (0.24%).

Who sold Galmed Pharmaceuticals stock? Who is selling Galmed Pharmaceuticals stock?

Galmed Pharmaceuticals' stock was sold by a variety of institutional investors in the last quarter, including GRT Capital Partners L.L.C..

How do I buy Galmed Pharmaceuticals stock?

Shares of Galmed Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Galmed Pharmaceuticals stock cost?

One share of Galmed Pharmaceuticals stock can currently be purchased for approximately $4.25.

Galmed Pharmaceuticals (NASDAQ:GLMD) Chart for Wednesday, February, 22, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Galmed Pharmaceuticals (NASDAQ:GLMD)

Earnings History Chart

Earnings by Quarter for Galmed Pharmaceuticals (NASDAQ:GLMD)

Dividend History Chart

Dividend Payments by Quarter for Galmed Pharmaceuticals (NASDAQ:GLMD)

Last Updated on 2/22/2017 by MarketBeat.com Staff